Investigation of the Efficacy of Zonisamide in Alcohol Induced Hepatotoxicity
Abstract
Subject: This research aims to evaluate the histological changes in liver tissue induced by alcohol consumption and to assess the effectiveness of zonisamide in treating alcohol-related hepatotoxicity.
Materials and Methods: The study utilized 40 adult Wistar albino rats, divided into four groups: a control (sham), an ethanol group, a zonisamide group, and a combination of ethanol and zonisamide (ethanol+zonisamide). Each group underwent a four-day binge drinking protocol to mimic excessive alcohol intake observed in humans. Zonisamide was administered at a dose of 100 mg/kg daily. Post-treatment, the liver tissues were collected, stained with hematoxylin and eosin, and examined for histopathological changes.
Results: The control and zonisamide-only groups showed no abnormal liver or vascular alterations, indicating zonisamide's safety. In contrast, the ethanol group displayed significant liver damage, including vascular dilatation, congestion, and extensive cellular degeneration. Conversely, the ethanol+zonisamide group exhibited substantial histological improvements with noticeable reductions in vascular impairments and signs of hepatocyte regeneration, suggesting that zonisamide mitigates the detrimental effects of alcohol on the liver.
Conclusion: The study concludes that zonisamide has a protective effect against alcohol-induced liver damage. It appears to preserve the structural integrity of hepatocytes and supports cellular survival, potentially through its anti-inflammatory and antioxidant properties. These promising results advocate for further exploration of zonisamide as a therapeutic option for managing liver injuries associated with alcohol abuse. This study contributes significant insights into the therapeutic potential of zonisamide, encouraging more comprehensive investigations into its clinical applications in hepatology.
Keywords: Alcohol, Zonisamide, Hepatotoxicity
Keywords:
Alcohol, Zonisamide, HepatotoxicityDOI
https://doi.org/10.22270/jddt.v14i5.6594References
Rossow I, Mäkelä P. Public health thinking around alcohol-related harm: Why does per capita consumption matter? J Stud Alcohol Drugs. 2021;82(1):9-17.https://doi.org/10.15288/jsad.2021.82.9 PMid:33573718
Shmulewitz D, Aharonovich E, Witkiewitz K, Anton RF, Kranzler HR, Scodes J, et al. The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013. Am J Psychiatry [Internet]. 2021 Jun 1 [cited 2024 Apr 28];178(6):548-59. https://doi.org/10.1176/appi.ajp.2020.20050610 PMid:33472388 PMCid:PMC8222066
Şimşek Şeref, Dönmezdil Süleyman, Kakdaş Erkan, Özen Şakir. Diyarbakır Çocuk ve Ergen Madde Bağ. Araştırma ve Tedavi... Bağımlılık Dergisi. 2014;15(1):23-7.
Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology [Internet]. 2020 Jan 1 [cited 2024 Apr 28];71(1):306-33. https://doi.org/10.1002/hep.30866 PMid:31314133
Stokłosa I, Więckiewicz G, Stokłosa M, Piegza M, Pudlo R, Gorczyca P. Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective. Int J Environ Res Public Health [Internet]. 2023 Feb 1 [cited 2024 Apr 28];20(3). https://doi.org/10.3390/ijerph20031870 PMid:36767234 PMCid:PMC9915396
Pohl K, Moodley P, Dhanda AD. Alcohol's impact on the gut and liver. Nutrients. 2021 Sep 1;13(9). https://doi.org/10.3390/nu13093170 PMid:34579046 PMCid:PMC8472839
Dries SS, Seibert BS, Bastiani MF, Linden R, Perassolo MS. Evaluation of oxidative stress biomarkers and liver and renal functional parameters in patients during treatment a mental health unit to treat alcohol dependence. Drug Chem Toxicol. 2022;45(2):861-7. https://doi.org/10.1080/01480545.2020.1780251 PMid:32567384
Pohl K, Moodley P, Dhanda AD. Alcohol's impact on the gut and liver. Nutrients. 2021 Sep 1;13(9). https://doi.org/10.3390/nu13093170 PMid:34579046 PMCid:PMC8472839
Dries SS, Seibert BS, Bastiani MF, Linden R, Perassolo MS. Evaluation of oxidative stress biomarkers and liver and renal functional parameters in patients during treatment a mental health unit to treat alcohol dependence. Drug Chem Toxicol. 2022;45(2):861-7. https://doi.org/10.1080/01480545.2020.1780251 PMid:32567384
Pohl K, Moodley P, Dhanda AD. Alcohol's impact on the gut and liver. Nutrients. 2021 Sep 1;13(9). https://doi.org/10.3390/nu13093170 PMid:34579046 PMCid:PMC8472839
Dries SS, Seibert BS, Bastiani MF, Linden R, Perassolo MS. Evaluation of oxidative stress biomarkers and liver and renal functional parameters in patients during treatment a mental health unit to treat alcohol dependence. Drug Chem Toxicol. 2022;45(2):861-7. https://doi.org/10.1080/01480545.2020.1780251 PMid:32567384
Pohl K, Moodley P, Dhanda AD. Alcohol's impact on the gut and liver. Nutrients. 2021 Sep 1;13(9). https://doi.org/10.3390/nu13093170 PMid:34579046 PMCid:PMC8472839
Dries SS, Seibert BS, Bastiani MF, Linden R, Perassolo MS. Evaluation of oxidative stress biomarkers and liver and renal functional parameters in patients during treatment a mental health unit to treat alcohol dependence. Drug Chem Toxicol. 2022;45(2):861-7. https://doi.org/10.1080/01480545.2020.1780251 PMid:32567384
Hossain MM, Weig B, Reuhl K, Gearing M, Wu LJ, Richardson JR. The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Na v 1.6. Exp Neurol. 2018 Oct 1;308:111-9. https://doi.org/10.1016/j.expneurol.2018.07.005 PMid:30017881 PMCid:PMC7404626
Huang CR, Chuang HY, Chen NC, Chen SF, Hsu CY, Chuang YC. Zonisamide Therapy Reduces Metabolic Consequences and Diminishes Nonalcoholic Fatty Liver Disease in Patients with Epilepsy. J Clin Med [Internet]. 2021 Jul 30 [cited 2024 Apr 28];10(15). https://doi.org/10.3390/jcm10153380 PMid:34362163 PMCid:PMC8347271
Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, et al. Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease. Digestive and Liver Disease. 2010 Jul;42(7):503-8. https://doi.org/10.1016/j.dld.2009.08.002 PMid:19766548
Hamada K, Lasek AW. Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder. Neurotherapeutics. 2020 Jan 1;17(1):4-16. https://doi.org/10.1007/s13311-019-00795-4 PMid:31617071 PMCid:PMC7007457
Anekwe C, Chandrasekaran P, Stanford FC. Ketogenic Diet-induced Elevated Cholesterol, Elevated Liver Enzymes and Potential Non-alcoholic Fatty Liver Disease. Cureus [Internet]. 2020 Jan 9 [cited 2024 Apr 28];12(1). https://doi.org/10.7759/cureus.6605 PMid:32064187 PMCid:PMC7008768
Cannella N, Ubaldi M, Masi A, Bramucci M, Roberto M, Bifone A, et al. Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future. Neurosci Biobehav Rev. 2019 Aug 1;103:384-98. https://doi.org/10.1016/j.neubiorev.2019.05.014 PMid:31112713 PMCid:PMC6692218
Faingold CL. The majchrowicz binge alcohol protocol: An intubation technique to study alcohol dependence in rats. Curr Protoc Neurosci. 2008;(SUPPL. 44). https://doi.org/10.1002/0471142301.ns0928s44 PMid:18634000
Doğru C, Aşir F. Effect of ellagic acid on damage caused by hepatic ischemia reperfusion in rats. Eur Rev Med Pharmacol Sci [Internet]. 2022 [cited 2024 Apr 28];26(22):8209-15. Available from: https://pubmed.ncbi.nlm.nih.gov/36459004/
He J, Zhang X, He W, Xie Y, Chen Y, Yang Y, et al. Neuroprotective effects of zonisamide on cerebral ischemia injury via inhibition of neuronal apoptosis. Braz J Med Biol Res [Internet]. 2021 [cited 2024 Apr 28];54(4):1-8. https://doi.org/10.1590/1414-431x202010498 PMid:33656055 PMCid:PMC7917778
Liver Journal E, Pandey B, Baral R, Kaundinnyayana A, Panta S. Promising hepatoprotective agents from the natural sources: a study of scientific evidence. SpringerB Pandey, R Baral, A Kaundinnyayana, S PantaEgyptian Liver Journal, 2023•Springer [Internet]. 2023 Dec 1 [cited 2024 Apr 28];13(1). https://doi.org/10.1186/s43066-023-00248-w
Kamitaki BK, Minacapelli CD, Zhang P, Wachuku C, Gupta K, Catalano C, et al. Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS). Epilepsy and Behavior. 2021 Apr 1;117. https://doi.org/10.1016/j.yebeh.2021.107832 PMid:33626490
D Salete-Granado, C Carbonell, D Puertas-Miranda, VJ Vega-Rodríguez, M García-Macia, Oxidative Stress, and Alcoholic Liver Disease: A Systematic Review and Potential Clinical Applications. Antioxidants https://doi.org/10.3390/antiox12071425 PMid:37507963 PMCid:PMC10376811
Published
Abstract Display: 497 
PDF Downloads: 434 PDF Downloads: 40 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.